Cargando…
Combined trastuzumab and radiation therapy for HER2-positive uterine serous carcinoma: A case report
Overexpression of HER2 in endometrial cancer is associated with poor prognosis, aggressive disease, and resistance to standard therapies. Recent studies have shown that HER2-targeted therapies, such as trastuzumab, can be effective in treating HER2-positive endometrial cancer in combination with che...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415829/ https://www.ncbi.nlm.nih.gov/pubmed/37575611 http://dx.doi.org/10.1016/j.gore.2023.101250 |